Neutropenia asociada al uso de cefepime en pacientes pediátricos con fibrosis quística / Neutropenia associated with the use of cefepime in pediatric patients with cystic fibrosis
Rev. chil. infectol
; 36(1): 112-114, feb. 2019. graf
Article
in Es
| LILACS
| ID: biblio-1042652
Responsible library:
CL1.1
RESUMEN
Resumen Las exacerbaciones pulmonares de causa infecciosa son una de las mayores complicaciones en los pacientes con fibrosis quística (FQ). Estas se asocian a un progresivo aumento en la morbilidad y mortalidad. El tratamiento antimicrobiano se realiza dependiendo del microorganismo aislado. Con frecuencia se utilizan antimicrobianos β-lactámicos, los cuales no están exentos de reacciones adversas. A continuación, se describen dos casos de neutropenia tras el uso prolongado de cefepime en pacientes con FQ.
ABSTRACT
Pulmonary exacerbations of infectious cause are one of the major complications in patients with cystic fibrosis (CF). These are associated with a progressive increase in morbidity and mortality. The treatment depending on the isolated microorganism. The β-lactam antibiotics are generally used which are not exempt from adverse reactions. Next, two report of neutropenia cases are described after prolonged use of cefepime in CF patients.
Key words
Full text:
1
Index:
LILACS
Main subject:
Cystic Fibrosis
/
Cefepime
/
Anti-Bacterial Agents
/
Neutropenia
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Child, preschool
/
Female
/
Humans
/
Male
Language:
Es
Journal:
Rev. chil. infectol
Journal subject:
DOENCAS TRANSMISSIVEIS
Year:
2019
Type:
Article